SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-063720
Filing Date
2015-11-09
Accepted
2015-11-09 16:03:31
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v423408_10q.htm 10-Q 490663
2 CERTIFICATION v423408_ex31-1.htm EX-31.1 11059
3 CERTIFICATION v423408_ex31-2.htm EX-31.2 11185
4 CERTIFICATION v423408_ex32-1.htm EX-32.1 4800
5 CERTIFICATION v423408_ex32-2.htm EX-32.2 4729
6 FINANCIAL INFORMATION v423408_ex99-1.htm EX-99.1 195200
  Complete submission text file 0001144204-15-063720.txt   6661302

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fbio-20150930.xml EX-101.INS 1663181
8 XBRL TAXONOMY EXTENSION SCHEMA fbio-20150930.xsd EX-101.SCH 57628
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20150930_cal.xml EX-101.CAL 42659
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20150930_def.xml EX-101.DEF 354710
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20150930_lab.xml EX-101.LAB 426877
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20150930_pre.xml EX-101.PRE 414596
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 151215566
SIC: 2834 Pharmaceutical Preparations